Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The CSMS was defined by the European Academy of Allergy and Immunology Taskforce as a standardised tool to assess clinical effects of allergen-specific immunotherapy (AIT). The aim of this study is to validate the CSMS as a tool to assess the clinical effects of Depigoid AIT, so that the CSMS can be used in future studies as a primary endpoint as well as a comparative parameter.
Epistemonikos ID: e4db11912a3215317ebeb37dff7d5aedcc8348cc
First added on: May 22, 2024